[SLRX] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
01-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -10.08%
YoY- -2.81%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 571 1,243 165 246 336 113 0 -
PBT -3,074 -1,784 -1,385 -9,052 -8,805 -11,363 -7,078 -12.96%
Tax -42 62 0 0 0 0 0 -
NP -3,074 -1,784 -1,385 -9,052 -8,805 -11,363 -7,078 -12.96%
Tax Rate - - - - - - - -
Total Cost 3,646 3,028 1,549 9,297 9,140 11,476 7,078 -10.45%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -538.05 -143.51 -840.76 -3,687.09 -2,624.15 -10,083.98 0.00 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -1.72 -3.20 -11.48 -313.66 -321.24 -440.98 -294.26 -57.52%
EPS Diluted -1.72 -3.20 -11.48 -313.66 -321.24 -440.98 -294.26 -57.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.